Mineralys Therapeutics (MLYS) Rule 144: 3,000-share cashless exercise
Rhea-AI Filing Summary
Mineralys Therapeutics, Inc. reported a Rule 144 notice for the sale of 3,000 shares of Common Stock via a broker-assisted cashless exercise on 06/17/2026. The filing shows proceeds of $75,000 and identifies the seller as Daphne Karydas. The transaction is described as an exercise of employee stock options.
Positive
- None.
Negative
- None.
Insights
Rule 144 notice documents a cashless exercise and resale intent for 3,000 shares.
The filing lists a broker-assisted cashless exercise on 06/17/2026 that generated $75,000 for the reported 3,000 shares. It explicitly states the method as an exercise of employee stock options, which is a common compensation liquidity event.
Timing and distribution mechanics beyond the exercise are not detailed here; subsequent Form 4s or resale filings would show any open-market sales. Cash-flow treatment is as stated in the excerpt.
Key Figures
Key Terms
Rule 144 regulatory
broker-assisted cashless exercise financial
exercise of employee stock options financial
FAQ
What did MLYS file on June 17, 2026?
Who is the selling party in the MLYS Rule 144 filing?
What method was used to effect the transaction in the MLYS filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.